Dipeptidyl peptidase-4 (DPP-4) inhibitors are a relatively new class of oral diabetes drugs. Also known as gliptins, they are usually prescribed for people with type 2 diabetes who have not responded ...
Dipeptidyl peptidase-4 (DPP-4), also known as the T-cell antigen CD26, is a multi-functional protein which, besides its catalytic activity, also functions as a binding protein and a ligand for a ...
Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Kurashiki, Japan Aim: At present, daily DPP-4 inhibitors are quite frequently prescribed in subjects with type 2 diabetes ...
Among patients with type 2 diabetes, no differences were found with biguanides vs DPP-4 inhibitors in major cardiac or cerebrovascular events, diabetic complications, or death. Biguanides vs ...
DPP-4 exists as both a membrane-bound and soluble form. DPP-4 has historically been associated with its capacity to metabolize incretin hormones. Recent studies have identified additional functions of ...
CXCR3 is a chemokine receptor with three ligands: CXCL9, CXCL10, and CXCL11. Cancer patients with low CXCL9 or CXCL10 levels exhibit a reduced response to the main immune checkpoint inhibitor PD-1, as ...
Findings from a study published in Acta Diabetologica support that treatment with dipeptidyl peptidase-4 (DPP-4) inhibitors is associated with better vitamin D balance in patients with type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback